Selenium

The Recommended Dietary Allowance (RDA) for most adults is 55 micrograms (mcg) per day. For therapeutic supplementation, healthcare providers may recommend:

• General Supplementation: 50 mcg to 200 mcg daily.
• Parenteral Nutrition: 20 mcg to 60 mcg daily added to IV fluids, depending on the patient's metabolic state.
• Upper Limit (UL): The Tolerable Upper Intake Level for adults is 400 mcg per day from all sources (food and supplements).

Pediatric dosing is strictly based on age and weight:

• 0-6 months: 15 mcg/day (Adequate Intake).
• 7-12 months: 20 mcg/day.
• 1-3 years: 20 mcg/day.
• 4-8 years: 30 mcg/day.
• 9-13 years: 40 mcg/day.
• 14-18 years: 55 mcg/day.

Renal Impairment

Patients with chronic kidney disease (CKD) or those on hemodialysis may require adjusted doses, as selenium levels can be altered by the dialysis process. Monitoring of serum selenium levels is recommended.

Hepatic Impairment

No specific dose adjustments are generally required for mild to moderate hepatic impairment, though the liver is a primary site for selenoprotein synthesis.

Elderly Patients

No specific age-related dose adjustments are typically necessary, though clinicians should consider overall nutritional status and renal function.

• Administration: Oral selenium can be taken with or without food. Taking it with a meal may reduce the risk of gastrointestinal upset.
• Consistency: It is best taken at the same time each day to maintain steady levels.
• Storage: Store oral supplements in a cool, dry place away from direct sunlight and moisture.

If a dose is missed, take it as soon as remembered. If it is almost time for the next scheduled dose, skip the missed dose. Do not double the dose to catch up.

Acute selenium toxicity (selenosis) is serious. Signs include a garlic-like breath odor, metallic taste, hair loss, brittle nails, and neurological disturbances. In case of suspected overdose, contact a poison control center or emergency services immediately.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.

At standard RDA levels, side effects are rare. However, at higher supplemental doses, patients may experience:

• Nausea: A feeling of sickness in the stomach.
• Diarrhea: Loose or watery stools.
• Garlic Breath: A distinct odor on the breath caused by methylated selenium metabolites.

• Fatigue: Unusual tiredness or lack of energy.
• Irritability: Feeling easily annoyed or frustrated.
• Mild Hair Thinning: Slight increase in hair shedding.

• Skin Rash: Development of dermatitis or itchy patches.
• Nail Discoloration: White spots or streaks on the fingernails.

> Warning: Stop taking Selenium and call your doctor immediately if you experience any of these.

• Selenosis (Chronic Toxicity): Characterized by significant hair loss (alopecia), thickened or brittle nails, and peripheral neuropathy (tingling or numbness in the hands and feet).
• Severe Gastrointestinal Distress: Persistent vomiting and abdominal pain.
• Neurological Changes: Tremors, lightheadedness, or facial flushing.
• Respiratory Distress: Difficulty breathing, which may occur in acute high-dose toxicity.

Prolonged intake above the Tolerable Upper Intake Level (400 mcg/day) can lead to chronic selenosis. Some observational studies have suggested a potential link between long-term high selenium levels and an increased risk of Type 2 Diabetes, though this remains a subject of clinical debate.

No FDA black box warnings exist for Selenium as a nutritional supplement or selenious acid injection.

Report any unusual symptoms to your healthcare provider.

Selenium is essential for health, but the margin between a therapeutic dose and a toxic dose is narrower than for many other vitamins. Patients should avoid taking multiple supplements containing selenium (e.g., a multivitamin plus a standalone selenium pill) without calculating the total daily intake.

No FDA black box warnings for Selenium.

• Toxicity Risk (Selenosis): The primary risk associated with Selenium is chronic toxicity. Healthcare providers typically monitor patients on long-term high-dose therapy.
• Surgery: There is some evidence that selenium may increase the risk of bleeding when combined with other supplements. It is generally recommended to discuss discontinuation with a surgeon at least two weeks before elective procedures.
• Skin Cancer Risk: Some studies (such as the Nutritional Prevention of Cancer trial) suggested that selenium supplementation might increase the risk of squamous cell carcinoma in individuals already at high risk for skin cancer.

For patients receiving Selenium via parenteral nutrition or high-dose therapy, clinicians may monitor:

• Serum Selenium Levels: To ensure levels remain within the reference range (typically 70–150 ng/mL).
• Thyroid Function Tests: TSH, T3, and T4 levels, especially in patients with existing thyroid disorders.
• Blood Glucose: Due to the theoretical risk of insulin resistance with high-dose chronic use.

Selenium does not typically interfere with the ability to drive or operate heavy machinery.

Excessive alcohol consumption can lead to selenium deficiency by interfering with absorption and increasing urinary excretion. While there is no direct contraindication, alcohol should be consumed in moderation.

Selenium supplements can generally be stopped without a tapering period, unless they are being used to treat a diagnosed deficiency under medical supervision.

> Important: Discuss all your medical conditions with your healthcare provider before starting Selenium.

There are no absolute drug contraindications where Selenium must never be used; however, it should not be used in patients with known hypersensitivity to any selenium-containing product.

• Anticoagulants/Antiplatelets (e.g., Warfarin, Clopidogrel): Selenium may theoretically increase the risk of bleeding. Healthcare providers should monitor prothrombin time (PT/INR) closely if high-dose selenium is initiated.
• Sedatives (e.g., Barbiturates): Animal studies suggest selenium might prolong the effects of sedative medications, though human data is limited.

• Statins (HMG-CoA Reductase Inhibitors): Some research suggests that antioxidant cocktails (including selenium, Vitamin C, and Vitamin E) might reduce the effectiveness of niacin and statins in raising HDL ("good") cholesterol levels.
• Chemotherapy: Selenium's antioxidant properties might theoretically interfere with the mechanism of certain chemotherapy drugs that rely on oxidative stress to kill cancer cells. Consult an oncologist before use.

• Brazil Nuts: A single Brazil nut can contain 68–91 mcg of selenium. Regular consumption of Brazil nuts alongside supplements can quickly lead to intake exceeding the 400 mcg upper limit.

• Zinc: High doses of zinc may interfere with the absorption of selenium if taken simultaneously.
• Antioxidant Supplements: Taking Selenium with high doses of Vitamin C or E may have synergistic effects, but also potentially complicates the management of cholesterol medications.

Selenium supplementation is not known to significantly interfere with standard laboratory assays, though it will obviously increase measured serum selenium concentrations.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.

• Hypersensitivity: Known allergic reaction to selenium or any component of the formulation.
• Acute Selenium Toxicity: Selenium should not be administered to individuals already showing signs of selenosis.

• High Risk of Non-Melanoma Skin Cancer: Patients with a history of squamous cell carcinoma should use selenium supplements with caution.
• Type 2 Diabetes: Individuals with poorly controlled diabetes or those at high risk should discuss supplementation with their doctor, as some data suggests a correlation between high selenium levels and increased fasting glycemia.

There is no established cross-sensitivity between selenium and other minerals, though patients allergic to yeast should avoid selenium-enriched yeast products.

> Important: Your healthcare provider will evaluate your complete medical history before prescribing Selenium.

FDA Pregnancy Category: Not formally assigned for supplements, but selenium is considered safe when taken within the RDA (60 mcg/day for pregnant women). Selenium is essential for fetal development, particularly for the brain and thyroid. However, intake should not exceed the 400 mcg upper limit due to potential risks to the fetus.

Selenium is naturally excreted in human breast milk. The RDA for lactating women is 70 mcg/day. Supplementation within these limits is generally considered safe and necessary for the infant's nutrition.

Selenium is vital for growth and immune function in children. Dosing must be carefully managed by a pediatrician to avoid toxicity, as children have lower tolerable upper limits than adults. It is not approved for high-dose therapeutic use in children unless a deficiency is clinically confirmed.

Older adults may have reduced dietary intake of selenium. While supplementation may be beneficial, clinicians should monitor renal function, as decreased clearance could theoretically increase the risk of accumulation.

Selenium is primarily excreted by the kidneys. In patients with severe renal impairment or end-stage renal disease (ESRD), the half-life of selenium may be prolonged, necessitating lower doses and frequent monitoring.

No specific dose adjustments are required, but patients with severe liver disease should be monitored for their ability to synthesize selenoproteins.

> Important: Special populations require individualized medical assessment.

Selenium functions as a structural component of the enzyme glutathione peroxidase, which catalyzes the reduction of hydroperoxides and lipid peroxides, thereby protecting cells from oxidative damage. It is also a critical component of iodothyronine deiodinase enzymes, which facilitate the peripheral conversion of the pro-hormone thyroxine (T4) to the biologically active triiodothyronine (T3) by removing an iodine atom.

The pharmacodynamic effect of selenium is delayed, as it must be incorporated into proteins during synthesis. The onset of maximal antioxidant effect typically occurs after several weeks of consistent intake. The duration of effect depends on the turnover rate of the specific selenoproteins.

| Parameter | Value |

|---|---|

| Bioavailability | 50% - 90% (Form dependent) |

| Protein Binding | >95% (as Selenoprotein P and Albumin) |

| Half-life | 24 hours (Initial); 15-20 days (Terminal) |

| Tmax | 2 - 8 hours |

| Metabolism | Hepatic (Methylation) |

| Excretion | Renal (50-60%), Fecal, Respiratory |

• Molecular Formula: Se (Elemental)
• Molecular Weight: 78.971 g/mol
• Solubility: Varies by form; Sodium selenite is highly water-soluble.
• Description: A non-metal chemical element that behaves as a semiconductor.

Selenium is classified as a Trace Element and Nutritional Supplement. It is often grouped with other antioxidants like Vitamin E.